Code | 97605 | ||||||||||
MA number | 68/0105/03-S | ||||||||||
Product Form: | plu igf 1x25 mg+1x solv.(liek.inj.skl.+liek.inj.+adaptér na liekovku) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 28.04.2003 |
Pediatric warnings: | Yes |
Dokument: | DHPC risperidon_paliperidon 10 10 2013.pdf |
Dokument: | DHPC Risperdal Consta 24 5 2010.pdf |
SPC: | SPC_RISPERDAL CONSTA_06_2021.pdf |
PIL: | PIL_RISPERDAL CONSTA_06_2021.pdf |
Safety feature | Yes |
Data update: | 08.04.2019 |